|
1 Iwai T, Hara A, Niwa M, et al. Temporal profile of nuclear DNA fragmentation in situ in gerbil hippocampus following transient forebrain ischemia. Brain Res, 1995, 671(2): 305–308.
|
|
2 Dong EB, Ran LR, Feng ZQ, et al. Protection effect of sheng mai injection on postasphyxied brain damage. Chin J Child Health Care, 1998, 6(1): 32–34.[董文斌，冉隆瑞，冯志强，等．生脉注射液对窒息后脑损伤保护作用的研究. 中国儿童保健杂志，1998, 6(1): 32–34.]
|
|
3 Tyagi SC, Kumar SG, Haas SJ, et al. Post–transcriptional regulation of extracellular matrix metalloproteinase in human heart end–stage failure secondary to ischemic cardiomyopathy. J Mol Cell Cardiol, 1996, 28(7): 1415–1428.
|
|
4 Hozumi A, Nishimura Y, Nishiuma T, et al. Induction of MMP–9 in normal human bronchial epithelial cells by TNF–alpha via NF–kappa B–mediated pathway. Am J Physiol Lung Cell Mol Physiol, 2001, 281(6): L1444–1452.
|
|
5 Alexander JP, Acott TS. Involvement of protein kinase C in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci, 2001, 42(12): 2831–2838.
|
|
6 Ducharme A, Franz S, Aikawa M, et al. Targeted deletion of matrix metalloproteinase–9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest, 2000, 106: 55–62.
|
|
7 Tyagi SC, Kumar SG, Haas SJ, et al. Post–transcriptional regulation of extracellular matrix metalloproteinase in human heart end–stage failure secondary to ischemic cardiomyopathy. J Mol Cell Cardiol, 1996, 28(7): 1415–1428.
|
|
8 Seeland U, Haeuseler C, Hinrichs R, et al. Myocardial fibrosis in transforming growth factor–beta 1(TGF–beta 1) transgenic mice is associated with inhibition of interstitial collagenase. Eur J Clin Invest, 2002, 32(5): 295–303.
|
|
9 Thomas CV, Coker ML, Zellner JL, et al. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end–stage dilated cardiomyopathy. Circulation, 1998, 97(17): 1708–1715.
|
|
10 Spinale FG, Coker ML, Bond BR, et al. Myocardial matrix degradation and metallopro–teinase activation in the failing heart: A potential therapeutic target. Cardiovasc Res, 2000, 46(2)：225–238.
|
|
11 Luo HL, He ZY, Feng B, et al. Clinical research on bFGF and TGF–β1 expression and heart hypertrophy. J Clin Cardiol, 2001, 17(2): 83–84. [罗惠兰，何作云，冯兵，等. 碱性成纤维细胞生长因子和转化生长因子β1表达与心肌肥大的研究. 临床心血管病杂志，2001, 17(2): 83–84.]
|
|
12 Danielsen CC, Wiggers H, Andersen HR. Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion. J Mol Cell Cardiol, 1998, 30(7): 1431–1442.
|
|
13 Cheung PY, Sawicki G, Wozniak M, et al. Matrix metalloproteinase–2 contributes to ischemia–reperfusion injury in the heart. Circulation, 2000, 101(15)：1833–1839.
|